Hutchmed (China)
(LSE) HCM
Hutchmed (China) Financials at a Glance
Market Cap
$191.91B
Revenue (TTM)
$602.20M
Net Income (TTM)
$466.88M
EPS (TTM)
$40.36
P/E Ratio
5.45
Dividend
$0.00
Beta (Volatility)
-0.30 (Low)
Dividend
$0.00
Beta (Volatility)
-0.30 (Low)
Price
$2.26
Volume
9,625
Open
$219.00
Price
$2.26
Volume
9,625
Open
$219.00
Previous Close
$220.00
Daily Range
$219.00 - $226.00
52-Week Range
$190.98 - $292.00
Dividend
$0.00
Beta (Volatility)
-0.30 (Low)
Price
$2.26
Volume
9,625
Open
$219.00
Previous Close
$220.00
Daily Range
$219.00 - $226.00
52-Week Range
$190.98 - $292.00
HCM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Hutchmed (China)
Industry
Pharmaceuticals
Sector
Health CareEmployees
1,796
CEO
Chig Fung Cheng
Website
www.hutch-med.comHeadquarters
Hong Kong, HK
HCM Financials
Key Financial Metrics (TTM)
Gross Margin
19%
Operating Margin
-3%
Net Income Margin
1%
Return on Equity
46%
Return on Capital
-1%
Return on Assets
26%
Earnings Yield
18.35%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$191.91B
Shares Outstanding
872.33M
Volume
9.63K
Short Interest
0.00%
Avg. Volume
40.07K
Financials (TTM)
Gross Profit
$212.22M
Operating Income
$54.59M
EBITDA
$41.28M
Operating Cash Flow
$64.67M
Capital Expenditure
$14.15M
Free Cash Flow
$78.82M
Cash & ST Invst.
$1.37B
Total Debt
$97.76M
Hutchmed (China) Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$138.84M
-9.2%
Gross Profit
$55.05M
-12.3%
Gross Margin
39.65%
N/A
Market Cap
$191.91B
N/A
Market Cap/Employee
$105.97M
N/A
Employees
1,811
N/A
Net Income
$227.48M
+1663.3%
EBITDA
$1.30M
+112.2%
Quarterly Fundamentals
Net Cash
$1.27B
+69.5%
Accounts Receivable
$147.63M
-5.1%
Inventory
$41.13M
-18.4%
Long Term Debt
$70.04M
+10.3%
Short Term Debt
$27.85M
+5.9%
Return on Assets
26.29%
N/A
Return on Invested Capital
-0.81%
N/A
Free Cash Flow
$41.08M
-64.5%
Operating Cash Flow
$36.45M
-83.0%